RecruitingNCT03657693
MRI in BPD Subjects
MRI for Quantitative Measurement of Pulmonary Growth and Development in Term and Extremely Pre-Term Babies in the BPD Center of Excellence
Sponsor
Children's Hospital Medical Center, Cincinnati
Enrollment
160 participants
Start Date
May 4, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The investigators are wanting to learn more about early development of the lungs and to help them better understand prematurity and the development of a breathing disorder call BPD (Bronchopulmonary Dysplasia)
Eligibility
Max Age: 4 Months
Inclusion Criteria1
- any term age NICU patient
Exclusion Criteria5
- \- ECMO,
- Evidence of congenital diseases that may affect lung development, such as congenital diaphragmatic hernia,
- Suspected muscular dystrophy or neurologic disorder that may affect lung development.
- Significant genetic or chromosomal abnormalities that may affect lung development
- Evidence of any respiratory infection at the time of imaging (imaging may be rescheduled for a common viral infection such as a cold).
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTNICU MRI
MRI device that is not FDA approved.
DIAGNOSTIC_TESTPolysomnography
Polysomnography to better determine obstruction index in the airway.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03657693
Related Trials
Lung Ultrasound Score for Early Prediction of Bronchopulmonary Dysplasia in Preterm Newborns
NCT076331844 locations
Pharmacokinetics and Placental Transfer of Caffeine
NCT075701211 location
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
NCT0689783950 locations
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
NCT052853451 location
IVIG Trial for the Treatment of Bronchopulmonary Dysplasia
NCT069253601 location